Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain

Status unconfirmed · Phase 3

Conditions studied: Constipation, Impaction, and Bowel Obstruction, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Naloxone may be effective in treating constipation that may be caused by opioid pain medications such as morphine. PURPOSE: Phase III trial to determine the effectiveness of naloxone in relieving constiption in patients who are receiving opioids for chronic pain.

Key facts

Study ID

NCT00020605

Run by

Dana-Farber Cancer Institute

Starts

2000-05-01

Last updated by the study team

2018-12-13

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.